FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.

Acinetobacter baumannii Animals Anti-Bacterial Agents / therapeutic use Drug Development Mice Models, Animal Rabbits Swine United States United States Food and Drug Administration
FDA animal models antibacterial antibiotics drug development humanized dose pneumonia regulatory workshop

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
16 12 2020
Historique:
pubmed: 28 10 2020
medline: 22 6 2021
entrez: 27 10 2020
Statut: epublish

Résumé

The U.S. Food and Drug Administration (FDA) hosted a public workshop entitled "Advancing Animal Models for Antibacterial Drug Development" on 5 March 2020. The workshop mainly focused on models of pneumonia caused by

Identifiants

DOI: 10.1128/AAC.01983-20 PMID: 33106262 PMC: PMC7927847
pubmed: 33106262
pii: AAC.01983-20
doi: 10.1128/AAC.01983-20
pmc: PMC7927847
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

PLoS One. 2019 Jul 18;14(7):e0219824
pubmed: 31318907
Antimicrob Agents Chemother. 2019 Aug 23;63(9):
pubmed: 31235620
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32015048
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32122895
J Vis Exp. 2018 Jun 28;(136):
pubmed: 30010650
Pathog Dis. 2015 Jul;73(5):
pubmed: 25857733

Auteurs

James M Byrne (JM)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA James.Byrne@fda.hhs.gov.
Oak Ridge Institute of Science and Education, Oak Ridge, Tennessee, USA.
ORCID: 0000-0003-4796-4934

Ursula Waack (U)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Oak Ridge Institute of Science and Education, Oak Ridge, Tennessee, USA.
ORCID: 0000-0003-4517-6790

Edward A Weinstein (EA)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Abhay Joshi (A)

Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID: 0000-0002-8721-6503

Simone M Shurland (SM)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Dmitri Iarikov (D)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Jürgen B Bulitta (JB)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Orlando, Florida, USA.
ORCID: 0000-0001-7352-3097

Binh An Diep (BA)

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

Tina Guina (T)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC, USA.

William W Hope (WW)

Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
ORCID: 0000-0001-6187-878X

Matthew B Lawrenz (MB)

Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
ORCID: 0000-0003-1505-5429

Alexander J Lepak (AJ)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Brian M Luna (BM)

Department of Molecular Microbiology and Immunology, Keck School of Medicine of USC, Los Angeles, California, USA.
ORCID: 0000-0001-6718-4551

Lynn Miesel (L)

Pharmacology Discovery Services, Ltd., New Taipei City, Taiwan.

Andrew J Phipps (AJ)

Tunnell Government Services, Biomedical Advanced Research and Development Authority, Washington, DC, USA.

Thomas J Walsh (TJ)

Transplantation-Oncology Infectious Diseases Program, Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine of Cornell University, New York, New York, USA.

William Weiss (W)

PreClinical Services, UNT System College of Pharmacy, Fort Worth, Texas, USA.

Thushi Amini (T)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

John J Farley (JJ)

Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Articles similaires

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

State and National Estimates of the Cost of Emergency Department Pediatric Readiness and Lives Saved.

Craig D Newgard, Amber Lin, Jeremy D Goldhaber-Fiebert et al.
1.00
Humans Emergency Service, Hospital Child Child, Preschool Infant

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Classifications MeSH

questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Moraxellaceae › Acinetobacter › Acinetobacter baumannii › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Eucaryotes › Animaux › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Techniques d'investigation › Développement de médicament › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Techniques d'investigation › Modèles animaux › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Lagomorpha › Lapins › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Suidae › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › FDA Public Workshop Summary: Advancing Animal...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Gouvernement › Agences gouvernementale américaines › Department of Health and Human Services (USA) › Public Health Service (USA) › Food and Drug Administration (USA) › FDA Public Workshop Summary: Advancing Animal...